Company news
Viridian Therapeutics, Inc. news in 2021
Viridian Therapeutics, Inc.'s news releases, calls and decks from 2021, newest first.
Viridian Therapeutics Announces First Subject Dosed in Phase 1/2 Clinical Trial of VRDN-001 for Thyroid Eye Disease (TED)
December 19, 2021
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)
November 14, 2021
Viridian Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
November 3, 2021
Viridian Therapeutics to Present at Upcoming Investor Conferences
November 2, 2021
Viridian Therapeutics Submits Investigational New Drug Application for VRDN-001, an IGF-1R antibody for the treatment of Thyroid Eye Disease, to the U.S. Food and Drug Administration
October 13, 2021
Viridian Therapeutics to Present Preclinical Data on VRDN-001 and VRDN-002 at the 90th Annual Meeting of the American Thyroid Association
September 29, 2021
Viridian Therapeutics Announces Closing of Public Offering of Shares of Common Stock and Preferred Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
September 22, 2021
Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock and Preferred Stock
September 20, 2021
Viridian Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
August 10, 2021
Viridian Therapeutics to Participate in the Wedbush PacGrow Healthcare Virtual Conference
August 4, 2021
Viridian Therapeutics Appoints Kristian Humer as Chief Financial Officer and Chief Business Officer
July 25, 2021
Viridian Therapeutics Appoints Jennifer Moses, CPA to the Board of Directors and as Chair of the Audit Committee
July 14, 2021
Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
July 13, 2021
Viridian Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference
July 6, 2021
Viridian Therapeutics to Participate in the JMP Securities Life Sciences Conference
June 9, 2021
Viridian Therapeutics to Participate in Upcoming Investor Conferences
May 13, 2021
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
May 5, 2021
Viridian Therapeutics Reports 2020 Financial Results and Provides Corporate Updates
March 24, 2021
Viridian Therapeutics To Host Conference Call Discussing Fourth Quarter And Full Year 2020 Results And Corporate Update
March 8, 2021
Viridian Therapeutics to Present at Three Upcoming Investor Conferences
February 21, 2021
miRagen Therapeutics Announces Company Name Change to Viridian Therapeutics and New Executive Appointments, Including Expansion of Leadership Team
January 18, 2021